title: From authority recommendations to fact-sheets--a future for guidelines.
abstract: ADA/EASD recommendations and diabetes expert consensus statements are not evidence-based. Reform of guideline development is urgently needed. Overriding governance and composition of the guideline committee is a key problem. Methodologists without important conflicts of interest should lead the development process and have primary responsibility. The rating of the quality of evidence should be separated from making the recommendations, transparency has to be increased and conflicts of interest must be tackled. Patient needs are not yet met in guidelines. Patients increasingly demand concise, easy-to-read summaries of the benefits and risks of medicines together with more comprehensive scientific data. However, patient participation in individual decision making is not considered in guidelines. Guidelines do not provide the information necessary for informed or shared decision making. Study fact-sheets and drug facts boxes should be included in practice guidelines. It is timely to consider patient needs from the outset of the development of future guidelines.
authors.affiliation: Unit of Health Sciences and Education, University of Hamburg, Martin-Luther-King Platz 6, 20146, Hamburg, Germany. Ingrid_Muehlhauser@uni-hamburg.de
authors.forename: I
authors.initials: I
authors.lastname: Mühlhauser
mesh_terms: D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D005060:Europe; D019317:Evidence-Based Medicine / Q000592:standards; D017408:Guidelines as Topic; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000517:prevention & control / Q000523:psychology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007258:Informed Consent / Q000592:standards; D008019:Life Style; D012307:Risk Factors; D012955:Societies, Medical / Q000592:standards; D014481:United States
chemical_list: D007004:Hypoglycemic Agents
references.citation: Diabetologia. 2009 Jan;52(1):17-30
references.pmid: 18941734
references.citation: BMJ. 2008 Apr 26;336(7650):924-6
references.pmid: 18436948
references.citation: Ann Intern Med. 2010 Jun 1;152(11):738-41
references.pmid: 20479011
references.citation: Lancet. 2009 Feb 28;373(9665):774-9
references.pmid: 18835641
references.citation: Lancet. 2007 Jun 2;369(9576):1883-1889
references.pmid: 17493676
references.citation: Ann Intern Med. 2009 Apr 21;150(8):516-27
references.pmid: 19221371
references.citation: BMJ. 2004 Oct 30;329(7473):990-1
references.pmid: 15514320
references.citation: JAMA. 2009 Jan 28;301(4):429-31
references.pmid: 19176446
references.citation: Diabetologia. 2010 Jul;53(7):1258-69
references.pmid: 20352408
references.citation: J Clin Epidemiol. 2010 Jun;63(6):620-6
references.pmid: 20434024
references.citation: Patient Educ Couns. 2010 Mar;78(3):316-28
references.pmid: 20005067
references.citation: J Clin Epidemiol. 2008 Jun;61(6):521-4
references.pmid: 18471654
references.citation: Lancet. 2010 Jun 26;375(9733):2203-4
references.pmid: 20609960
references.citation: JAMA. 2008 Oct 15;300(15):1814-6
references.pmid: 18854545
references.citation: Diabetologia. 2006 Aug;49(8):1742-6
references.pmid: 16718464
references.citation: Health Expect. 2007 Dec;10(4):358-63
references.pmid: 17986072
references.citation: Diabetologia. 2010 Jul;53(7):1247-9
references.pmid: 20419286